Browse > Article

Expression, Purification, and Characterization of C-Terminal Amidated Glucagon in Streptomyces lividans  

Qi, Xiaoqiang (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College)
Jiang, Rong (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College)
Yao, Cheng (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College)
Zhang, Ren (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College)
Li, Yuan (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College)
Publication Information
Journal of Microbiology and Biotechnology / v.18, no.6, 2008 , pp. 1076-1080 More about this Journal
Abstract
Glucagon, a peptide hormone produced by alpha-cells of Langerhans islets, is a physiological antagonist of insulin and stimulator of its secretion. In order to improve its bioactivity, we modified its structure at the C-terminus by amidation catalyzed by a recombinant amidase in bacterial cells. The human gene coding for glucagon-gly was PCR amplified using three overlapping primers and cloned together with a rat ${\alpha}$-amidase gene in plasmid pMGA. Both genes were expressed under control of the strong constitutive promoter of aph and secretion signal melC1 in Streptomyces lividans. With Phenyl-Sepharose 6 FF, Q-Sepharose FF, SP-Sepharose FF chromatographies and HPLC, the peptide was purified to about 93.4% purity. The molecular mass of the peptide is 3.494 kDa as analyzed by MALDI TOF, which agrees with the theoretical mass value of the C-terminal amidated glucagon. The N-terminal sequence of the peptide was also determined, confirming its identity with human glucagon at the N-terminal part. ELISA showed that the purified peptide amide is bioactive in reacting with glucagon antibodies.
Keywords
Glucagon; amide; purification; Streptomyces lividans;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 3  (Related Records In Web of Science)
연도 인용수 순위
1 Anne, J. and L. Van Mellaert. 1993. Streptomyces Iividans as host for heterologous protein production. FEMS Microbiol. Lett. 114: 121-128   DOI   ScienceOn
2 Bender, E., K. P. Koller and J. W. Engels. 1990. Secretory synthesis of human interleukin-2 by Streptomyces lividans. Gene. 86: 227-232   DOI   ScienceOn
3 Binnie, C., D. Jenish, D. Cossar, A. Szabo, D. Trudeau, P. Krygsman, L. T. Malek, and D. I. H. Stewart. 1997. Expression and characterization of soluble human erythropoietin receptor made in Streptomyces lividans 66. Protein Expr. Purif. 11: 271-278   DOI   ScienceOn
4 Brawner, M., G. Poste, M. Rosenberg, and J. Westpheling. 1991. Streptomyces: A host for heterologous gene expression. Curr. Opin. Biotechnol. 2: 674-681   DOI   ScienceOn
5 Chiasson, J. L. and A. D. Cherrington. 1983. In: Glucagon and Liver Glucose Output in Vivo (Glucagon I, Handbook of Experimental Pharmacology), pp. 361-382. Springer-Verlag, Berlin, Germany
6 Choi, N. S., K. H. Yoo, K. S. Yoon, K. T. Chang, P. J. Maeng, and S. H. Kim. 2005. Identification of recombinant subtilisins. J. Microbiol. Biotechnol. 15: 35-39   과학기술학회마을
7 Stewart, J. M., E. J. York, R. L. Baldwin, and K. R. Shoemaker. 1985. Nature of the charged-group effect on the stability of the C-peptide helix. Proc. Natl. Acad. Sci. USA 82: 2349-2353
8 Lichenstein, H., M. E. Brawner, L. M. Miles, C. A. Meyers, P. R. Young, P. L. Simon, and T. Eckhardt. 1988. Secretion of interleukin-1 beta and Escherichia coli galactokinase by Streptomyces lividans. J. Bacteriol. 170: 3924-3929   DOI
9 Moody, A. J., F. Norris, and K. Norris. 1987. The secretion of glucagon by transformed yeast strains. FEBS Lett. 212: 302- 306   DOI   ScienceOn
10 Ray, M. V., P. Van Duyne, and A. H. Bertelsen. 1993. Production of recombinant salmon calcitonin by in vitro amidation of an Escherichia coli produced precursor peptide. Biotechnology (NY) 11: 64-70   DOI
11 White, J. W. and G. F. Saunders. 1986. Structure of the human glucagon gene. Nucleic Acids Res. 14: 4719-4730   DOI   ScienceOn
12 Fornwald, J. A., M. J. Donovan, R. Gerber, J. Keller, D. P. Taylor, E. J. Arcuri, and M. E. Brawner. 1993. Soluble forms of the human T cell receptor CD4 are efficiently expressed by Streptomyces lividans. Biotechnology 11: 1031-1036   DOI   ScienceOn
13 Brawner, M. E. 1994. Advances in heterologous gene expression by Streptomyces. Curr. Opin. Biotechnol. 5: 475-481   DOI   ScienceOn
14 Roman Esipov, S., N. Vasily Stepanenko, and I. Alexandr Gurevich. 2006. Production and purification of recombinant human glucagon overexpressed as intein fusion protein in Escherichia coli. Protein Peptide Lett. 13: 343-347   DOI   ScienceOn
15 Staub, A., L. Sinn, and O. K. Behrens. 1955. Purification and crystallization of glucagon. J. Biol. Chem. 214: 619-632
16 Ausubel, F. M. 1995. Short Protocols in Molecular Biology, 3rd Ed. John Wiley & Sons, Inc
17 Wu, B.Y. and Y. Li. 2000. Studies of cloning and expression of rat $\alpha$-amidase gene in Streptomyces lividans. Chin. J. Biotechnol. 16: 574-577
18 Unger, R. H. 1976. Diabetes and the alpha cell. Diabetes. 25: 136-151   DOI
19 Binnie, C., J. D. Cossar, and D. I. H. Stewart. 1997. Heterologous biopharmaceutical protein expression in Streptomyces. TIBTECH 15: 315-320   DOI   ScienceOn
20 Na, K. H., S. C. Kim, K. S. Seo, S. H. Lee, W. B. Kim, and K. C. Lee. 2005. Purification and characterization of recombinant human follicle stimulating hormone produced by Chinese hamster ovary cells. J. Microbiol. Biotechnol. 15: 395-402   과학기술학회마을
21 Van Mellaert, L., C. Dillen, P. Proost, E. Sablon, R. DeLeys, A. Van Broekhoven, H. Heremans, J. Van Damme, H. Eyssen, and J. Anne. 1994. Efficient secretion of biologically active mouse tumor necrosis factor $\alpha$ by Streptomyces lividans. Gene 150: 153-158   DOI   ScienceOn
22 Kimball, C. P. and J. R. Murlin. 1923. Aqueous extracts of pancreas III. Some precipitation reactions of insulin. J. Biochem. 58: 337-346
23 Hong, B., B. Wu, and Y. Li. 2003. Production of C-terminal amidated recombinant salmon calcitonin in Streptomyces lividans. Appl. Biochem. Biotechnol. 110: 113-123
24 Ishizaki, J., M. Tamaki, M. Shin, H. Tsuzuki, K. Yoshikawa, H. Teraoka, and N. Yoshida. 1992. Production of recombinant human glucagon in the form of a fusion protein in Escherichia coli recovery of glucagon by sequence-specific digestion. Appl. Microbiol. Biotechnol. 36: 483-486
25 Kieser, T., M. J. Bibb, M. J. Buttner, K. F. Chater, and D. A. Hopwood. 2000. Practical Streptomyces Genetics. Crowes, Norwich, England
26 Krstenansky, J. L., D. Trivedi, D. Johnson, and V. J. Hruby. 1986. Conformational considerations in the design of a glucagon analogue with increased receptor binding and adenylate cyclase potencies. J. Am. Chem. Soc. 108: 1696-1698   DOI
27 Unson, C. G., D. Andreu, M. Ellen Gurzenda, and R. B. Merrifield. 1987. Synthetic peptide antagonists of glucagons. Proc. Natl. Acad. Sci. USA 84: 4083-4087